Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2011 (376 publications)

no pagination
Klayton TL, Ruth K, Horwitz EM, Uzzo RG, Kutikov A, Chen DY, Sobczak M, Buyyounouski MK. Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiotherapy and Oncology. 2011 Dec;101(3):508-12.   PMCID: PMC3225561
Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA. Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer. The oncologist. 2011 Dec;16(12):1675-83.   PMCID: not NIH funded
Makhov PB, Golovine KV, Kutikov A, Canter DJ, Rybko VA, Roshchin DA, Matveev VB, Uzzo RG, Kolenko VM. Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis. 2011 Dec;32(12):1773-81.   PMCID: PMC3220607
Matullo CM, O'Regan KJ, Curtis M, Rall GF. CNS Recruitment of CD8+ T Lymphocytes Specific for a Peripheral Virus Infection Triggers Neuropathogenesis during Polymicrobial Challenge. PLoS Pathog. 2011 Dec;7(12):e1002462.   PMCID: PMC3245314
Mehra R, Serebriiskii IG, Dunbrack RL, Robinson MK, Burtness B, Golemis EA. Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer. Drug Resistance Updates. 2011 Dec;14(6):260-79.   PMCID: PMC3195944
Pfau PR, Banerjee S, Barth BA, Desilets DJ, Kaul V, Kethu SR, Pedrosa MC, Pleskow DK, Tokar J, Varadarajulu S, Wang A, Song LM, Rodriguez SA. Sphincter of Oddi manometry. Gastrointestinal endoscopy. 2011 Dec;74(6):1175-80.   PMCID: not NIH funded
Remakus S, Sigal LJ. Gamma Interferon and Perforin Control the Strength, but Not the Hierarchy, of Immunodominance of an Antiviral CD8(+) T Cell Response. Journal of Virology. 2011 Dec;85(23):12578-84.   PMCID: PMC3209401
Rosental B, Brusilovsky M, Hadad U, Oz D, Appel MY, Afergan F, Yossef R, Rosenberg LA, Aharoni A, Cerwenka A, Campbell KS, Braiman A, Porgador A. Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44. Journal of Immunology. 2011 Dec;187(11):5693-702.   PMCID: PMC3269963
Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. THE INFLUENCE OF TOTAL NODES EXAMINED, NUMBER OF POSITIVE NODES, AND LYMPH NODE RATIO ON SURVIVAL AFTER SURGICAL RESECTION AND ADJUVANT CHEMORADIATION FOR PANCREATIC CANCER: A SECONDARY ANALYSIS OF RTOG 9704. International Journal of Radiation Oncology Biology Physics. 2011 Dec;81(5):1328-35.   PMCID: PMC3038247
Taglieri DM, Monasky MM, Knezevic I, Sheehan KA, Lei M, Wang X, Chernoff J, Wolska BM, Ke YB, Solaro RJ. Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. Journal of Molecular and Cellular Cardiology. 2011 Dec;51(6):988-96.   PMCID: PMC3208757
Tannir NM, Wong YN, Kollmannsberger CK, Ernstoff MS, Perry DJ, Appleman LJ, Posadas EM, Cho D, Choueiri TK, Coates A, Gupta N, Pradhan R, Qian J, Chen JH, Scappaticci FA, Ricker JL, Carlson DM, Michaelson MD. Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure. European Journal of Cancer. 2011 Dec;47(18):2706-14.   PMCID: not NIH funded
Tsimberidou AM, Lewis N, Reid T, Burris H, Urban P, Tan EY, Anand S, Uehara C, Kurzrock R. Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 2011 Dec;68(6):1507-16.   PMCID: not NIH funded
Tu ZG, Aird KM, Bitler BG, Nicodemus JP, Beeharry N, Xia B, Yen TJ, Zhang RG. Oncogenic Ras Regulates BRIP1 Expression to Induce Dissociation of BRCA1 from Chromatin, Inhibit DNA Repair, and Promote Senescence. Developmental Cell. 2011 Dec;21(6):1077-91.   PMCID: PMC3241855
Wang ZX, Oh E, Clapp DW, Chernoff J, Thurmond DC. Inhibition or Ablation of p21-activated Kinase (PAK1) Disrupts Glucose Homeostatic Mechanisms in Vivo. Journal of Biological Chemistry. 2011 Dec;286(48):41359-67.   PMCID: PMC3308848
Levy MH. Palliative care and oncology: integration leads to better care. Oncology (Williston Park). 2011 Nov 30;25(13):1275.
Levy MH. Palliative care and oncology: integration leads to better care. Oncology (Williston Park). 2011 Nov 30;25(13):1275.
Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim HR, Yerrum S, Sharma CG, Nicolas E, Balagurunathan Y, Ross EA, Jordan VC. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18879-86.   PMCID: PMC3223472
Anastassiadis T, Deacon SW, Devarajan K, Ma HC, Peterson JR. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nature Biotechnology. 2011 Nov;29(11):1039-U117.   PMCID: PMC3230241
Asge Technology Committee, Tokar JL, Banerjee S, Barth BA, Desilets DJ, Kaul V, Kethi SR, Pedrosa MC, Pfau PR, Pleskow DK, Varadarajulu S, Wang A, Song LM, Rodriguez SA. Drug-eluting/biodegradable stents. Gastrointestinal endoscopy. 2011 Nov;74(5):954-8.   PMCID: not NIH funded
Benson AB, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fleshman JW, Fuchs CS, Grem JL, Knol JA, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett C. Colon cancer. J Natl Compr Canc Netw. 2011 Nov;9(11):1238-90.   PMCID: not NIH funded
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2011


Last updated on Wednesday, September 06, 2017